BioAtla (BCAB) Other Non-Current Assets (2020 - 2026)
BioAtla's (BCAB) quarterly Other Non-Current Assets came in at $163000.0 in Q1 2026, little changed quarter-over-quarter from $163000.0 in Q4 2025.
BioAtla (BCAB) Other Non-Current Assets (2020 - 2026) Analysis & Trends
BioAtla's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $163000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $163000.0 in Q1 2026; TTM through Mar 2026 was $163000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $163000.0, changed N/A from the prior year.
- Other Non-Current Assets held at $163000.0 in Q1 2026 per BCAB's latest filing, from $163000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $163000.0 in Q2 2025 and bottomed at $154000.0 in Q1 2022.
- The 5-year median for Other Non-Current Assets is $154000.0 (2022), against an average of $156846.2.
- Across the five-year window, Other Non-Current Assets rose 0.65% in 2022 and retreated 0.65% in 2023, its largest moves.
- Year by year, Other Non-Current Assets stood at $154000.0 in 2022, then changed by 0.0% to $154000.0 in 2023, then changed by 0.0% to $154000.0 in 2024, then gained by 5.84% to $163000.0 in 2025, then changed by 0.0% to $163000.0 in 2026.
- Per Business Quant, the three latest BCAB Other Non-Current Assets figures stand at $163000.0 (Q1 2026), $163000.0 (Q4 2025), and $163000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | BioAtla | 5.74 Mn | 5.74 Mn | - | 163,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 163,000.00 |
| Dec 31, 2025 | 163,000.00 |
| Sep 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 163,000.00 |
| Mar 31, 2024 | 154,000.00 |
| Dec 31, 2023 | 154,000.00 |
| Sep 30, 2023 | 154,000.00 |
| Jun 30, 2023 | 154,000.00 |
| Mar 31, 2023 | 154,000.00 |
| Dec 31, 2022 | 154,000.00 |
| Sep 30, 2022 | 154,000.00 |
| Jun 30, 2022 | 155,000.00 |
| Mar 31, 2022 | 154,000.00 |
| Dec 31, 2021 | 154,000.00 |
| Sep 30, 2021 | 154,000.00 |
| Jun 30, 2021 | 154,000.00 |
| Mar 31, 2021 | 154,000.00 |
| Dec 31, 2020 | 154,000.00 |